GlassScriptPhysician profile
Patrick T Prendergast
NPI 1417036757
$1,010.19
in general payments reported to CMS, 2019-2025
11 companies · $616 in 2025
The $616 reported for 2025 was more than what 92% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.47 · 2020: $150 · 2021: $99.66 · 2022: $20.38 · 2023: $99.92 · 2024: $13.53 · 2025: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $466 · Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $465.96 |
| Food and Beverage | $263.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Septodont INC. | $559.88 | 2025 | Biodentine |
| Zimmer Biomet Holdings, INC. | $149.52 | 2020 | |
| Biolase, INC. | $88.31 | 2022-2023 | Waterlase Iplus |
| Gc America INC. | $51.03 | 2021-2025 | Cerasmart |
| Orapharma, A Division of Bausch Health US, LLC | $35.33 | 2021 | |
| Carestream Dental, LLC | $27.65 | 2021 | |
| Dentsply Sirona INC | $25.46 | 2019-2023 | Cavitron |
| Straumann USA LLC | $25.16 | 2021 | |
| Kettenbach LP | $18.00 | 2023 | |
| Elevate Oral Care | $16.32 | 2025 | Advantage Arrest, Fluorimax 5000, Just Right 5000 |
| Philips North America LLC | $13.53 | 2024 | (E17) Power Toothbrush Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Prendergast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.